Portfolio company
Rheoxtech
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops a catheter-based reperfusion system that delivers controlled reoxygenation to prevent heart damage for hospitals and interventional cardiologists treating heart attack patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
CorFlow Therapeutics
This medical device company develops a platform to diagnose and treat microvascular obstruction in heart attack patients for interventional cardiologists.
CryoTherapeutics SA
This company develops an intravascular cryotherapy catheter system to stabilise high-risk coronary plaques for interventional cardiologists to prevent heart attacks.
CorFlow Therapeutics AG
This company develops medical devices for diagnosing and treating microvascular obstruction in heart attack patients for use by interventional cardiologists in catheterisation laboratories.
preCARDIA
This company develops catheter-based systems for heart failure specialists to treat patients suffering from acute decompensated heart failure and volume overload.
Miracor Medical SA
This company develops a pressure-controlled intermittent coronary sinus occlusion system to treat patients with impaired cardiac function and heart attacks.
CardioSight
CardioSight develops an intravascular optical visualization and interventional delivery platform for surgeons to perform minimally invasive heart repairs without open-heart surgery.
Robocath
This company develops robotic platforms for interventional cardiology to assist healthcare professionals in treating vascular diseases and performing coronary angioplasty.
CardioMech
CardioMech develops a transcatheter-based artificial chordae delivery system for hospitals to treat patients suffering from degenerative mitral regurgitation without open-heart surgery.
